image description

Category: Research and Discovery

LRA Announces Inaugural Awards Promoting Diversity in Lupus Research

NEW YORK, NY, June 9, 2022. The Lupus Research Alliance (LRA), the world’s leading private funder of lupus research, today announced inaugural recipients of Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research. The Diversity in Lupus Research Award funding mechanisms aim to address underrepresentation of minorities in the scientific research profession. Lupus […] Read More

2018 Lupus Insight Prize Presented to Dr. Betty Diamond

2018 Lupus Insight Prize Presented to Dr. Betty Diamond Funds Study of Common Hypertension Drugs to Treat Lupus June 21, 2018 The Lupus Research Alliance has awarded its 2018 Lupus Insight Prize to Betty Diamond, MD, for a project to test commonly used drugs for high blood pressure as potential treatments for cognitive and emotional […] Read More

2017-18 Research Portfolio Summary

June 5, 2018 The Lupus Research Alliance is driven by one central goal — to improve the lives of people living with the disease, today and in the long term. We believe that scientific research is the most powerful way we can achieve this goal. Further, we believe that by both pushing the limits of scientific exploration and […] Read More

2017 Novel Research Grants – Meet the Awardees

July 28, 2017. The Lupus Research Alliance is delighted to announce the recipients of our 2017 Novel Research Grants. These ten grantees continue a commitment to bold and innovative research that aims to discover safe, effective treatments and a cure for lupus. Mridu Acharya, PhD Benaroya Research Institute at Virginia Mason Dr. Acharya is investigating the […] Read More

Pivotal LRA-Funded Research Shared at Annual Rheumatology Meeting

November 15, 2021 The Lupus Research Alliance (LRA) supports research into causes and mechanisms of lupus, and identification of targets supporting the development of new therapies or cures for lupus patients. At this year’s meeting of the American College of Rheumatology (ACR), 17 LRA-funded researchers presented their work to share discoveries with the thousands of […] Read More

Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting

November 9, 2021 Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2021, November 3-9. Bringing you the most relevant news for our lupus community, following are summaries of key research presented at the meeting: New Data on Approved Lupus Treatments […] Read More

A “Call to Arms” for the Lupus Community

August 18, 2021 Many lupus patients are at risk for COVID-19 infection because of treatment with corticosteroids and other immunosuppressive medications and will be eligible for booster vaccination. However, there are large gaps in our understanding of who will benefit from the booster vaccines, what strategies will improve response to the vaccine and the best […] Read More

Positive Research Results on Potential Lupus Treatments Shared at Major Medical Meeting

June 8, 2021 The annual European Congress of Rheumatology (EULAR 2021) brought much good news of potential new treatments for systemic lupus erythematosus (SLE).  Following are highlights: Rituximab Plus Belimumab Taking belimumab after rituximab may help lupus according to data from the BEAT-LUPUS trial presented at the 2021 EULAR Virtual Congress by the trial lead investigator […] Read More

Promising New Lupus Treatments Highlighted ACR Annual Meeting

Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2020. These studies include phase I trials, which test for side effects and a safe dosage; larger phase II trials, which test for effectiveness and further gauge safety; and large phase III trials, which confirm […] Read More